𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of DNA Synthesis in Caco-2 Cells by Oxidative Stress (Amelioration by Epidermal Growth Factor)

✍ Scribed by J. A. Engler; A. Gupta; R. K. Rao

Book ID
110376697
Publisher
Springer US
Year
1999
Tongue
English
Weight
275 KB
Volume
44
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Inhibition of epidermal growth factor re
Inhibition of epidermal growth factor receptor activity by retinoic acid in glioma cells
✍ Peter A. Steck; Azra Hadi; Reuben Lotan; W. K. Alfred Yung πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 791 KB

The growth inhibitory effects of exogenously added retinoic acid (RA) on various cultured human glioma cells was observed to be heterogenous, with an ID,, ranging from lo-' M to no response. The protein tyrosine kinase activity of epidermal growth factor receptor (EGF-receptor) appeared to parallel

Insulin-like growth factor binding prote
Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-Ξ² in mink lung epithelial cells
✍ Feng Dong; Hai-Bin WU; Jiang Hong; Matthew M. Rechler πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 243 KB πŸ‘ 2 views

## Abstract Insulin‐like growth factor binding protein‐3 (IGFBP‐3) has been proposed to mediate the growth inhibitory effects of transforming growth factor (TGF)‐β in breast and prostate cancer cells. Both TGF‐β and exogenous IGFBP‐3 inhibit DNA synthesis in Mv1 mink lung epithelial cells (CCL64).

Inhibition of epidermal growth factor-st
Inhibition of epidermal growth factor-stimulated DNA synthesis by a bovine sialoglycopeptide inhibitor occurs at an intracellular level
✍ Charles C. Bascom; Behrooz G. Sharifi; Terry C. Johnson πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 524 KB

The control of cell proliferation involves the complex interaction between growth factors and growth inhibitors. We have examined this interaction with the mitogen epidermal growth factor (EGF) and a recently purified 18 kD, PI 3, sialoglycopeptide that reversibly inhibits cellular metabolism of a v